INTERNATIONAL PATENT: CORVUS PHARMACEUTICALS, INC. FILES APPLICATION FOR "USE OF ITK INHIBITORS AND CAR T-CELL THERAPY"

GENEVA, July 3 -- CORVUS PHARMACEUTICALS, INC. (901 Gateway Boulevard, 3rd FloorSouth San Francisco, CA 94080) filed a patent application (PCT/US2024/060702) for "USE OF ITK INHIBITORS AND CAR T-CELL THERAPY" on Dec 18, 2024. With publication no. WO/2025/137059, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MILLER, Richard, A. (901 Gateway Boulevard, 3rd FloorSouth San Francisco, CA 94080), HSU, Lih-Yun (901 Gateway Boulevard, 3rd FloorSouth San Francisco, CA 94080)

Abstract: Interleukin-2-inducible T-cell kinase inh...